US5474783A
(en)
*
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5656286A
(en)
*
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5719197A
(en)
*
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
CA2115840A1
(en)
*
|
1991-08-27 |
1993-03-04 |
Tsung-Min Hsu |
Transdermal formulation for administering prazosin
|
US6162456A
(en)
*
|
1992-09-24 |
2000-12-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
|
DE4313928C2
(de)
*
|
1993-04-28 |
1996-09-19 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
|
DE4319096C1
(de)
*
|
1993-06-08 |
1994-09-08 |
Kuhl Herbert Prof Dr Phil Nat |
Hormonales Mittel zur Vorbeugung und Behandlung arterieller Erkrankungen beim Mann
|
WO1995022970A1
(fr)
*
|
1994-02-28 |
1995-08-31 |
Teijin Limited |
Timbre renfermant du dinitrate d'isosorbide et etant prepare a l'aide d'un melange adhesif
|
DE4407742C1
(de)
*
|
1994-03-08 |
1995-06-22 |
Hexal Pharma Gmbh |
Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
|
US5714162A
(en)
*
|
1994-09-16 |
1998-02-03 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Scopolamine patch
|
IT1278545B1
(it)
*
|
1994-10-13 |
1997-11-24 |
Fime Fab It Motor Elett |
Sistema di fissaggio per l'arresto delle palette metalliche delle ventole di aspirazione centrifughe
|
DE4443888A1
(de)
*
|
1994-12-09 |
1996-06-13 |
Bayer Ag |
Dermal applizierbare Formulierungen von Parasitiziden
|
US5605701A
(en)
*
|
1995-02-17 |
1997-02-25 |
Eli Lilly And Company |
Transdermal formulation
|
DE19517145C2
(de)
*
|
1995-05-10 |
2000-02-24 |
Hexal Pharmaforschung Gmbh |
Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
|
US6316022B1
(en)
*
|
1995-06-07 |
2001-11-13 |
Noven Pharmaceuticals, Inc. |
Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
|
IL122484A0
(en)
*
|
1995-06-07 |
1998-06-15 |
Noven Pharma |
Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
|
HU228434B1
(en)
*
|
1995-06-07 |
2013-03-28 |
Ortho Mcneil Pharm Inc |
Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US5906830A
(en)
*
|
1995-09-08 |
1999-05-25 |
Cygnus, Inc. |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
|
US5730721A
(en)
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
US7094422B2
(en)
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US5725876A
(en)
*
|
1996-05-17 |
1998-03-10 |
Noven Pharmaceuticals Inc., |
Compositions and methods for using low-swell clays in nicotine containing dermal compositions
|
US5837289A
(en)
*
|
1996-07-23 |
1998-11-17 |
Grasela; John C. |
Transdermal delivery of medications using a combination of penetration enhancers
|
DE19635883A1
(de)
*
|
1996-09-04 |
1998-03-05 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
|
US6166081A
(en)
*
|
1997-10-09 |
2000-12-26 |
Kushnir; Moshe |
Methods and apparatus for treatment of Parkinson's disease
|
US6746688B1
(en)
|
1996-10-13 |
2004-06-08 |
Neuroderm Ltd. |
Apparatus for the transdermal treatment of Parkinson's disease
|
IL119417A
(en)
*
|
1996-10-13 |
2003-02-12 |
Moshe Kushnir |
Pharmaceutical composition for transdermal administration of levodopa for parkinson's disease
|
US5879701A
(en)
*
|
1997-02-28 |
1999-03-09 |
Cygnus, Inc. |
Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
|
US5976547A
(en)
*
|
1997-04-22 |
1999-11-02 |
Niblick Pharmaceuticals, Inc. |
Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
|
US7150881B2
(en)
*
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
GB9714650D0
(en)
*
|
1997-07-11 |
1997-09-17 |
Strakan Ltd |
Block copolymer
|
DE69833665T2
(de)
*
|
1997-08-08 |
2006-11-09 |
Duke University |
Zusammensetzungen zur vereinfachung von chirurgischen verfahren
|
US6711436B1
(en)
|
1997-08-08 |
2004-03-23 |
Duke University |
Compositions, apparatus and methods for facilitating surgical procedures
|
EP1356806A1
(en)
*
|
1997-09-12 |
2003-10-29 |
Columbia Laboratories (Bermuda) Limited |
A pharmaceutical composition for treating dysmenorrhea and premature labor
|
DE69819748T2
(de)
*
|
1997-09-12 |
2004-09-30 |
Columbia Laboratories (Bermuda) Ltd. |
Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
|
US5919476A
(en)
*
|
1997-09-29 |
1999-07-06 |
Pmt Corporation |
Reinforced gel sheeting for scar treatment
|
IL136042A
(en)
*
|
1997-11-10 |
2005-12-18 |
Cellegy Pharma Inc |
Alcohol-containing composition for topical application
|
WO1999026571A1
(en)
*
|
1997-11-25 |
1999-06-03 |
Theratech, Inc. |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
|
US20020102291A1
(en)
*
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US6210705B1
(en)
|
1997-12-15 |
2001-04-03 |
Noven Pharmaceuticals, Nc. |
Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US5900249A
(en)
*
|
1998-02-09 |
1999-05-04 |
Smith; David J. |
Multicomponent pain relief topical medication
|
DE19814257A1
(de)
*
|
1998-03-31 |
1999-10-07 |
Asta Medica Ag |
Brauseformulierungen
|
US20020188037A1
(en)
*
|
1999-04-15 |
2002-12-12 |
Chudzik Stephen J. |
Method and system for providing bioactive agent release coating
|
AU760408B2
(en)
|
1998-04-27 |
2003-05-15 |
Surmodics, Inc. |
Bioactive agent release coating
|
DE19818955C2
(de)
*
|
1998-04-28 |
2000-06-29 |
Lohmann Therapie Syst Lts |
Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat
|
DE19828273B4
(de)
*
|
1998-06-25 |
2005-02-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
|
DE19828274C2
(de)
*
|
1998-06-25 |
2002-11-28 |
Rottapharm Bv |
Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
|
DE19830649C2
(de)
*
|
1998-07-09 |
2003-04-10 |
Lohmann Therapie Syst Lts |
Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
|
DE19830648A1
(de)
*
|
1998-07-09 |
2000-01-13 |
Lohmann Therapie Syst Lts |
Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung
|
DE19834496B4
(de)
|
1998-07-31 |
2004-02-26 |
Beiersdorf Ag |
Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen
|
MXPA01001752A
(es)
*
|
1998-08-20 |
2002-04-08 |
3M Innovative Properties Co |
Parche en aerosol y sistema de aplicacion de medicamento.
|
NZ512788A
(en)
*
|
1998-12-07 |
2003-07-25 |
Elan Corp Plc |
Transdermal patch for delivering volatile liquid drugs
|
ATE288256T1
(de)
*
|
1999-01-14 |
2005-02-15 |
Noven Pharma |
Dermale zusammensetzungen
|
US20030170195A1
(en)
*
|
2000-01-10 |
2003-09-11 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for drug delivery
|
US6552024B1
(en)
|
1999-01-21 |
2003-04-22 |
Lavipharm Laboratories Inc. |
Compositions and methods for mucosal delivery
|
US6337086B1
(en)
|
1999-02-06 |
2002-01-08 |
Dow Corning Corporation |
Pressure sensitive adhesive compositions for transdermal drug delivery devices
|
DE19908787A1
(de)
*
|
1999-03-01 |
2000-09-14 |
Labtec Gmbh |
Transdermale Applikation von ß2-Sympathomimetika zur Behandlung obstruktiver Atemwegserkrankungen
|
DE60022174T2
(de)
*
|
1999-04-01 |
2006-02-16 |
Alza Corp., Mountain View |
Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir
|
DE19918105C1
(de)
|
1999-04-22 |
2000-09-21 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
|
US7063859B1
(en)
|
1999-04-28 |
2006-06-20 |
Noven Pharmaceuticals, Inc. |
Barrier film lined backing layer composition and method for topical administration of active agents
|
FR2793689B1
(fr)
*
|
1999-05-19 |
2001-08-24 |
Pf Medicament |
Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
|
US6962691B1
(en)
*
|
1999-05-20 |
2005-11-08 |
U & I Pharmaceuticals Ltd. |
Topical spray compositions
|
WO2000074661A2
(en)
|
1999-06-05 |
2000-12-14 |
Noven Pharmaceuticals, Inc. |
Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
|
AU6528400A
(en)
|
1999-08-23 |
2001-03-19 |
David M. Ockert |
Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
|
US6264973B1
(en)
|
1999-08-26 |
2001-07-24 |
Fei Enterprises, Ltd. |
Apparatus and method for anesthetizing the cervical region of a female
|
US7052714B1
(en)
*
|
1999-10-13 |
2006-05-30 |
Senju Pharmaceutical Co., Ltd |
Ophthalmic adhesive preparations for percutaneous adsorption
|
ATE287711T1
(de)
*
|
1999-11-29 |
2005-02-15 |
Novosis Ag |
Transdermalsystem zur abgabe von clonidin
|
US6974588B1
(en)
|
1999-12-07 |
2005-12-13 |
Elan Pharma International Limited |
Transdermal patch for delivering volatile liquid drugs
|
US6582724B2
(en)
|
1999-12-16 |
2003-06-24 |
Dermatrends, Inc. |
Dual enhancer composition for topical and transdermal drug delivery
|
US6562370B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
|
US6673363B2
(en)
|
1999-12-16 |
2004-01-06 |
Dermatrends, Inc. |
Transdermal and topical administration of local anesthetic agents using basic enhancers
|
US6645520B2
(en)
|
1999-12-16 |
2003-11-11 |
Dermatrends, Inc. |
Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
|
US6602912B2
(en)
|
2000-06-30 |
2003-08-05 |
Dermatrends, Inc. |
Transdermal administration of phenylpropanolamine
|
US6562368B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
US6558695B2
(en)
*
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
US6719997B2
(en)
|
2000-06-30 |
2004-04-13 |
Dermatrends, Inc. |
Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
|
US6586000B2
(en)
|
1999-12-16 |
2003-07-01 |
Dermatrends, Inc. |
Hydroxide-releasing agents as skin permeation enhancers
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
US6565879B1
(en)
|
1999-12-16 |
2003-05-20 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
|
US6562369B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
|
WO2001052823A2
(en)
|
2000-01-20 |
2001-07-26 |
Noven Pharmaceuticals, Inc. |
Compositions to effect the release profile in the transdermal administration of drugs
|
WO2001064149A1
(en)
*
|
2000-02-29 |
2001-09-07 |
Jie Zhang |
Improved transdermal drug patch
|
US6905016B2
(en)
*
|
2000-03-14 |
2005-06-14 |
Noven Pharmaceuticals, Inc. |
Packaging system for transdermal drug delivery systems
|
DE10012908B4
(de)
*
|
2000-03-16 |
2005-03-17 |
Lts Lohmann Therapie-Systeme Ag |
Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
|
KR100452972B1
(ko)
*
|
2000-05-16 |
2004-10-14 |
주식회사 삼양사 |
경피투여용 하이드로젤 조성물
|
US7674480B2
(en)
*
|
2000-06-23 |
2010-03-09 |
Teva Pharmaceutical Industries Ltd. |
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
|
GB0015617D0
(en)
*
|
2000-06-26 |
2000-08-16 |
Vectura Ltd |
Improved preparations for dermal delivery of active substances
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
JP2004504585A
(ja)
*
|
2000-07-14 |
2004-02-12 |
トランスフォーム ファーマシューティカルズ,インコーポレーティッド. |
化合物の組織バリア輸送を最適にするためのシステムおよび方法
|
US20080182293A1
(en)
*
|
2000-07-14 |
2008-07-31 |
Transform Pharmaceuticals, Inc. |
Computerized control of high-throughput transdermal experimental processing and digital analysis of comparative samples
|
US6852526B2
(en)
|
2000-07-14 |
2005-02-08 |
Transform Pharmaceuticals, Inc. |
Transdermal assay with magnetic clamp
|
US7172859B2
(en)
*
|
2000-07-14 |
2007-02-06 |
Transform Pharmaceuticals, Inc. |
System and method for optimizing tissue barrier transfer of compounds
|
EP1318843B1
(en)
*
|
2000-09-19 |
2013-04-17 |
Henkel AG & Co. KGaA |
Acryl adhesive useful in transdermal drug delivery systems
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
US20020198215A1
(en)
*
|
2000-10-23 |
2002-12-26 |
Lino Tavares |
Terazosin transdermal device and methods
|
US20040028724A1
(en)
*
|
2000-11-07 |
2004-02-12 |
Takaaki Terahara |
Pharmaceutical preparation of percutaneous absorption type
|
WO2002045701A2
(en)
*
|
2000-12-05 |
2002-06-13 |
Noven Pharmaceuticals, Inc. |
Crystallization inhibition of drugs in transdermal drug delivery systems
|
EP1216699A1
(de)
*
|
2000-12-21 |
2002-06-26 |
Schering Aktiengesellschaft |
Transdermalsystem enthaltend ein hochpotentes Gestagen
|
WO2002069942A1
(fr)
*
|
2001-03-07 |
2002-09-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Timbre adhesif
|
CZ307857B6
(cs)
*
|
2001-03-16 |
2019-07-03 |
Alza Corporation |
Transdermální náplast pro podávání fentanylu nebo jeho analogu
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
EP1875898A3
(en)
|
2001-03-16 |
2008-08-27 |
Alza Corporation |
Transdermal patch for administering fentanyl
|
DE10118282A1
(de)
*
|
2001-04-12 |
2002-12-05 |
Lohmann Therapie Syst Lts |
Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
|
US8728445B2
(en)
|
2001-05-01 |
2014-05-20 |
A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences |
Hydrogel Compositions
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
DE60239528D1
(de)
|
2001-05-01 |
2011-05-05 |
Corium International Redwood City |
Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
|
WO2002089849A1
(en)
*
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
DE60100994T2
(de)
*
|
2001-05-08 |
2004-07-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System für die Erzielung hoher Plasmaspiegel von Rotigotin in der Therapie von Morbus Parkinson
|
WO2002102390A1
(en)
*
|
2001-06-18 |
2002-12-27 |
Noven Pharmaceuticals, Inc. |
Enhanced drug delivery in transdermal systems
|
AU2002329763B2
(en)
*
|
2001-08-17 |
2007-11-08 |
Lavipharm Laboratories Inc. |
Composition and transdermal drug delivery device
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
WO2003022270A1
(en)
*
|
2001-09-13 |
2003-03-20 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of an enalapril ester
|
US6805878B2
(en)
|
2001-09-13 |
2004-10-19 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of ACE inhibitors
|
US8425892B2
(en)
|
2001-10-29 |
2013-04-23 |
Columbia Laboratories, Inc. |
Extended, controlled-release pharmaceutical compositions using charged polymers
|
US20030147972A1
(en)
*
|
2002-02-05 |
2003-08-07 |
Christopher W. Denver |
Method and composition for diminishing loss of color in flavors and fragrances
|
CA2478165A1
(en)
*
|
2002-03-11 |
2003-09-25 |
Janssen Pharmaceutica N.V. |
Sulfatase inhibiting progestogen-only contraceptive regimens
|
CN1652798A
(zh)
*
|
2002-03-11 |
2005-08-10 |
詹森药业有限公司 |
连续抑制硫酸酯酶的孕激素的激素替代疗法
|
US20030219471A1
(en)
*
|
2002-03-11 |
2003-11-27 |
Caubel Patrick Michel |
Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
|
JP2005526839A
(ja)
|
2002-04-23 |
2005-09-08 |
アルザ・コーポレーシヨン |
不正使用の可能性が低い経皮鎮痛薬システム
|
DE10220230A1
(de)
*
|
2002-05-06 |
2003-11-27 |
Sanol Arznei Schwarz Gmbh |
Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
DE10223835A1
(de)
*
|
2002-05-28 |
2003-12-11 |
Labtec Gmbh |
Pflaster, enthaltend Fentanylum
|
DE20321052U1
(de)
*
|
2002-05-28 |
2005-09-22 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
Pflaster, enthaltend Fentanylum
|
US7097850B2
(en)
*
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
US20030232087A1
(en)
*
|
2002-06-18 |
2003-12-18 |
Lawin Laurie R. |
Bioactive agent release coating with aromatic poly(meth)acrylates
|
JP4589721B2
(ja)
*
|
2002-06-20 |
2010-12-01 |
アスティオン デルマトロジー エイ/エス |
ポリヒドロキシアルカンの脂肪酸エステルおよびピリジンカルボキシ誘導体の新規複合体
|
BRPI0312007B1
(pt)
|
2002-06-25 |
2015-04-14 |
Acrux Dds Pty Ltd |
Composição farmacêutica para administração transcutânea de testosterona ou fentanil e uso da dita composição
|
DE60333566D1
(de)
*
|
2002-08-13 |
2010-09-09 |
Medtronic Inc |
Medizinische vorrichtung mit verbesserter haftung zwischen einem polymeren berzug und einem substrat
|
EP1530489A1
(en)
*
|
2002-08-13 |
2005-05-18 |
Medtronic, Inc. |
Active agent delivery system including a hydrophilic polymer, medical device, and method
|
JP2006502135A
(ja)
*
|
2002-08-13 |
2006-01-19 |
メドトロニック・インコーポレーテッド |
活性薬剤デリバリーの、システム、医学用装置、及び方法
|
US20040033251A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Medtronic, Inc. |
Active agent delivery system including a polyurethane, medical device, and method
|
US20040126323A1
(en)
*
|
2002-08-20 |
2004-07-01 |
Ihor Shevchuk |
Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent
|
AU2003268376A1
(en)
*
|
2002-08-30 |
2004-11-26 |
Watson Pharmaceuticals, Inc. |
Transdermal delivery systems and methods
|
US7040314B2
(en)
*
|
2002-09-06 |
2006-05-09 |
Philip Morris Usa Inc. |
Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols
|
US7241456B2
(en)
*
|
2002-10-25 |
2007-07-10 |
Australian Importers Ltd. |
Formulations for topical delivery of bioactive substances and methods for their use
|
US7449307B2
(en)
*
|
2002-10-28 |
2008-11-11 |
Transform Pharmaceuticals, Inc. |
Raised surface assay plate
|
US6908760B2
(en)
*
|
2002-10-28 |
2005-06-21 |
Transform Pharmaceuticals, Inc. |
Raised surface assay plate
|
US20040086551A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
EP2218448B1
(en)
|
2002-12-13 |
2015-09-23 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
US20040147534A1
(en)
*
|
2003-01-23 |
2004-07-29 |
Foote Mary Ann |
Topical composition and method for treating occlusive wounds
|
JP4363866B2
(ja)
*
|
2003-03-14 |
2009-11-11 |
リンテック株式会社 |
皮膚貼付材用シリコーン粘着剤組成物及びこれを用いた皮膚貼付材
|
GB0308734D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Uptake of macromolecules
|
US20040208917A1
(en)
*
|
2003-04-16 |
2004-10-21 |
Wilfried Fischer |
Transdermal systems for the release of clonidine
|
US7833545B2
(en)
|
2003-04-29 |
2010-11-16 |
The General Hospital Corporation |
Methods and devices for the sustained release of multiple drugs
|
US20040219195A1
(en)
*
|
2003-04-30 |
2004-11-04 |
3M Innovative Properties Company |
Abuse-resistant transdermal dosage form
|
US7182955B2
(en)
*
|
2003-04-30 |
2007-02-27 |
3M Innovative Properties Company |
Abuse-resistant transdermal dosage form
|
US8790689B2
(en)
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
ME00276B
(me)
|
2003-04-30 |
2011-05-10 |
Purdue Pharma Lp |
Transdermalni dozni oblik otporan na promjene koje sadrže komponentu aktivnog sredstva i komponentu suprotnog sredstva na mjestu koji je ispod sloja aktivnog sredstva
|
US20040237400A1
(en)
*
|
2003-05-27 |
2004-12-02 |
Weder Donald E. |
Plant package with floral wrapper with decorative portion
|
US7576226B2
(en)
*
|
2003-06-30 |
2009-08-18 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Process of making isomers of norelgestromin and methods using the same
|
EP1663179A1
(en)
*
|
2003-07-21 |
2006-06-07 |
Noven Pharmaceuticals, Inc. |
Composition and method for controlling drug delivery from silicone adhesive blends
|
JP2007502281A
(ja)
*
|
2003-08-13 |
2007-02-08 |
メドトロニック・インコーポレーテッド |
混和性ポリマー配合物を含む活性剤放出系、医療機器、及び方法
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
US8784874B2
(en)
*
|
2003-09-10 |
2014-07-22 |
Noven Pharmaceuticals, Inc. |
Multi-layer transdermal drug delivery device
|
CA2542778C
(en)
*
|
2003-10-28 |
2012-05-29 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery composition
|
US8586080B1
(en)
*
|
2003-10-28 |
2013-11-19 |
Noven Pharmaceuticals, Inc. |
Inhibiting crystallization of steroidal hormones in transdermal delivery systems
|
KR20060120678A
(ko)
|
2003-10-30 |
2006-11-27 |
알자 코포레이션 |
남용될 가능성이 감소된 경피용 진통제 시스템
|
AU2005210637B2
(en)
|
2004-01-30 |
2010-09-16 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Rapidly dissolving film for delivery of an active agent
|
AU2011203203B2
(en)
*
|
2004-03-09 |
2014-04-10 |
Mylan Technologies, Inc |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US20050202073A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Mylan Technologies, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US9205062B2
(en)
*
|
2004-03-09 |
2015-12-08 |
Mylan Pharmaceuticals, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US20060083772A1
(en)
*
|
2004-04-06 |
2006-04-20 |
Dewitt David M |
Coating compositions for bioactive agents
|
CA2563150A1
(en)
|
2004-04-06 |
2005-10-20 |
Surmodics, Inc. |
Coating compositions for bioactive agents
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
EP1791575B1
(en)
|
2004-08-05 |
2014-10-08 |
Corium International, Inc. |
Adhesive composition
|
JP2008510713A
(ja)
*
|
2004-08-20 |
2008-04-10 |
スリーエム イノベイティブ プロパティズ カンパニー |
半透明保護フィルムを有する経皮薬物送達デバイス
|
US20060078604A1
(en)
*
|
2004-10-08 |
2006-04-13 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery device including an occlusive backing
|
US20060078602A1
(en)
|
2004-10-08 |
2006-04-13 |
Noven Pharmaceuticals, Inc. |
Device for transdermal administration of drugs including acrylic polymers
|
US8246976B2
(en)
*
|
2004-10-08 |
2012-08-21 |
Noven Pharmaceuticals, Inc. |
Transdermal delivery of drugs based on crystal size
|
WO2006041907A2
(en)
|
2004-10-08 |
2006-04-20 |
Noven Pharmaceuticals, Inc. |
Transdermal delivery of estradiol
|
US8252320B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
CN101146523B
(zh)
|
2004-10-21 |
2010-12-29 |
杜雷科特公司 |
透皮给药系统
|
CA2589761A1
(en)
|
2004-12-07 |
2006-06-15 |
Surmodics, Inc. |
Coatings with crystallized active agent(s) and methods
|
KR100810947B1
(ko)
|
2005-01-28 |
2008-03-10 |
롬 앤드 하아스 컴패니 |
에멀젼 폴리머로부터 제조된 의료용 필름 및 제품
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
ITMI20050477A1
(it)
*
|
2005-03-23 |
2006-09-24 |
Bouty S P A |
Cerotto transdermico
|
GB0506139D0
(en)
*
|
2005-03-24 |
2005-05-04 |
Transphase Ltd |
A transdermal topical composition and its uses
|
US20060281775A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Applied Pharmacy Services, Inc. |
Two-component pharmaceutical composition for the treatment of pain
|
WO2007035940A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal norelgestromin delivery system
|
US20070104771A1
(en)
*
|
2005-09-23 |
2007-05-10 |
Jay Audett |
Transdermal galantamine delivery system
|
US8383149B2
(en)
*
|
2005-09-23 |
2013-02-26 |
Alza Corporation |
High enhancer-loading polyacrylate formulation for transdermal applications
|
US20090130188A9
(en)
|
2005-09-29 |
2009-05-21 |
National Starch And Chemical Investment Holding Company |
Acrylic pressure sensitive adhesives
|
EP1774964B1
(en)
|
2005-10-13 |
2014-08-06 |
Nitto Denko Corporation |
Nicotine transdermal preparation and production method thereof
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
EP1940368A2
(en)
*
|
2005-10-25 |
2008-07-09 |
Dow Corning Corporation |
Transdermal drug delivery system with acrylate or methacrylate functional pressure sensitive adhesive composition
|
KR20070059758A
(ko)
*
|
2005-12-07 |
2007-06-12 |
에스케이케미칼주식회사 |
비스테로이드성 항염증제와 국소마취제를 포함하는 경피투여 조성물
|
US9393218B2
(en)
*
|
2005-12-23 |
2016-07-19 |
Epinamics Gmbh |
Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
|
WO2007097428A1
(ja)
*
|
2006-02-23 |
2007-08-30 |
Mitsubishi Rayon Co., Ltd. |
(メタ)アクリル系重合体粒子、その製造方法、プラスチゾル及び物品
|
CA2643037C
(en)
*
|
2006-02-27 |
2014-08-05 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for delivery of amino-functional drugs
|
US20070225425A1
(en)
*
|
2006-03-24 |
2007-09-27 |
Nash Paul L |
Low tack elastomer composition, part and methods
|
DE102006019293A1
(de)
*
|
2006-04-21 |
2007-10-25 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
Pflaster, enthaltend ein Fentanyl Analogum
|
US8569416B2
(en)
|
2006-06-06 |
2013-10-29 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
US8614278B2
(en)
|
2006-06-06 |
2013-12-24 |
Dow Corning Corporation |
Silicone acrylate hybrid composition and method of making same
|
JP2009540052A
(ja)
*
|
2006-06-06 |
2009-11-19 |
ダウ・コーニング・コーポレイション |
シリコーンアクリレートハイブリッド組成物およびその製造方法
|
US20070287727A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Jacob Hiller |
Anti-Nicotine Treatment
|
JP2009543902A
(ja)
|
2006-07-10 |
2009-12-10 |
メディパックス インコーポレイテッド |
超弾性エポキシヒドロゲル
|
US8647664B2
(en)
|
2006-07-14 |
2014-02-11 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive preparation
|
MX2009004358A
(es)
*
|
2006-10-27 |
2009-06-17 |
Noven Pharma |
Suministro transdermico de derivados polares de cetoprofeno.
|
AU2007325918B2
(en)
|
2006-11-03 |
2013-10-17 |
Durect Corporation |
Transdermal delivery systems comprising bupivacaine
|
DE102006054732B4
(de)
*
|
2006-11-21 |
2010-12-30 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
|
PL2120896T3
(pl)
*
|
2007-01-11 |
2017-10-31 |
Drossapharm Ag |
Plaster aktywny medycznie
|
CN101589105B
(zh)
*
|
2007-01-23 |
2014-08-27 |
三菱丽阳株式会社 |
(甲基)丙烯酸系聚合物粒子、其制造方法、使用(甲基)丙烯酸系聚合物粒子的增塑溶胶组合物以及使用其的物品
|
WO2008097851A1
(en)
*
|
2007-02-02 |
2008-08-14 |
Warner Chilcott Company, Inc. |
Tetracycline compositions for topical administration
|
CN101147739B
(zh)
*
|
2007-07-06 |
2010-12-08 |
北京康倍得医药技术开发有限公司 |
含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
|
EA020208B1
(ru)
*
|
2007-07-10 |
2014-09-30 |
Эджайл Терапьютикс, Инк. |
Устройство доставки в кожу с изолирующим слоем in situ
|
AU2008289109B2
(en)
*
|
2007-08-17 |
2012-02-02 |
Centrexion Therapeutics Corporation |
High concentration local anesthetic formulations
|
RU2499583C2
(ru)
|
2007-10-15 |
2013-11-27 |
Алза Корпорейшн |
Заместительное трансдермальное введение фентанила один раз в день
|
US20090098191A1
(en)
*
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
JP2011505520A
(ja)
*
|
2007-12-03 |
2011-02-24 |
メディパックス インコーポレイテッド |
流体計量供給装置
|
JP2011506319A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
|
US9700552B2
(en)
*
|
2008-02-28 |
2017-07-11 |
Syntropharma Limited |
Pharmaceutical compositions for treatment of addiction
|
US8231906B2
(en)
|
2008-07-10 |
2012-07-31 |
Noven Pharmaceuticals, Inc. |
Transdermal estrogen device and delivery
|
WO2010014545A1
(en)
*
|
2008-07-28 |
2010-02-04 |
Dow Corning Corporation |
Composite article
|
WO2010019953A1
(en)
|
2008-08-15 |
2010-02-18 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations for treating non-neuropathic pain
|
JP5472756B2
(ja)
|
2008-10-02 |
2014-04-16 |
マイラン・インク |
多層接着ラミネートの作製方法
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
CA2751884C
(en)
|
2009-01-14 |
2018-09-25 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
JP5681883B2
(ja)
*
|
2009-03-27 |
2015-03-11 |
株式会社 メドレックス |
核酸を有効成分とする外用剤組成物
|
CN102803420B
(zh)
|
2009-04-24 |
2015-06-03 |
汉高知识产权控股有限责任公司 |
基于硅氧烷丙烯酸杂化聚合物的粘合剂
|
US8299079B2
(en)
*
|
2009-05-22 |
2012-10-30 |
Kaufman Herbert E |
Preparations and methods for ameliorating or reducing presbyopia
|
US9795617B2
(en)
|
2009-06-18 |
2017-10-24 |
Baucom Institute for Longevity and Life Enhancement, Inc. |
Hormone delivery system and method
|
US8658628B2
(en)
*
|
2009-06-18 |
2014-02-25 |
Karan Y. Baucom |
Hormone delivery system and method
|
US20110037455A1
(en)
*
|
2009-08-17 |
2011-02-17 |
Oren Navot |
System for measuring electrical power
|
CH701769A1
(de)
|
2009-09-08 |
2011-03-15 |
Schoeller Textil Ag |
Wiederbeladbare Ausrüstungen für Textilien und Formulierungen zur Beladung solcher Ausrüstungen.
|
WO2011032011A1
(en)
|
2009-09-10 |
2011-03-17 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
WO2011068722A1
(en)
*
|
2009-12-01 |
2011-06-09 |
Noven Pharmaceuticals, Inc. |
Transdermal testosterone device and delivery
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
JP5927506B2
(ja)
|
2010-04-13 |
2016-06-01 |
レルマダ セラピューティクス、インク. |
1−メチル−2’,6’−ピペコロキシリダイドの皮膚医薬組成物および使用方法
|
CN102947370B
(zh)
|
2010-04-23 |
2016-05-11 |
汉高知识产权控股有限责任公司 |
硅酮-丙烯酸共聚物
|
EP2601245A1
(en)
|
2010-08-05 |
2013-06-12 |
Biofilm IP, LLC |
Cyclosiloxane-substituted polysiloxane compounds, compositions containing the compounds and methods of use thereof
|
US8668675B2
(en)
|
2010-11-03 |
2014-03-11 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
US20120123369A1
(en)
*
|
2010-11-12 |
2012-05-17 |
David Harry Melik |
Elastomeric compositions that resist force loss and disintegration
|
US9017305B2
(en)
|
2010-11-12 |
2015-04-28 |
The Procter Gamble Company |
Elastomeric compositions that resist force loss and disintegration
|
US10905652B2
(en)
|
2011-03-23 |
2021-02-02 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US9498447B2
(en)
|
2011-03-23 |
2016-11-22 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US10292937B2
(en)
|
2011-03-23 |
2019-05-21 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
US8916588B2
(en)
|
2011-03-23 |
2014-12-23 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods for treatment of attention deficit hyperactivity disorder
|
US9119809B2
(en)
|
2011-03-23 |
2015-09-01 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US8927010B2
(en)
|
2011-03-23 |
2015-01-06 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US9283214B2
(en)
|
2011-03-23 |
2016-03-15 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US11241391B2
(en)
|
2011-03-23 |
2022-02-08 |
Ironshore Pharmaceuticals & Development, Inc. |
Compositions for treatment of attention deficit hyperactivity disorder
|
US9603809B2
(en)
|
2011-03-23 |
2017-03-28 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods of treatment of attention deficit hyperactivity disorder
|
EP2688557B1
(en)
|
2011-03-23 |
2017-08-23 |
Ironshore Pharmaceuticals & Development, Inc. |
Methods and compositions for treatment of attention deficit disorder
|
DE102011114411A1
(de)
*
|
2011-09-26 |
2013-03-28 |
Lts Lohmann Therapie-Systeme Ag |
Pflaster mit einstellbarer Okklusion
|
EP2584016A1
(en)
|
2011-10-21 |
2013-04-24 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
ES2885523T3
(es)
|
2011-11-23 |
2021-12-14 |
Therapeuticsmd Inc |
Formulaciones y terapias de reposición hormonal de combinación naturales
|
JP2013139554A
(ja)
|
2011-11-29 |
2013-07-18 |
Dow Corning Corp |
シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
|
EP2847249A4
(en)
|
2012-03-14 |
2016-12-28 |
Medipacs Inc |
SMART POLYMER MATERIALS WITH EXCESSIVE REACTIVE MOLECULES
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
AR092999A1
(es)
|
2012-10-15 |
2015-05-13 |
Noven Pharma |
Composiciones y metodos para la administracion transdermica de metilfenidato
|
TW201431570A
(zh)
|
2012-11-22 |
2014-08-16 |
Ucb Pharma Gmbh |
用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
AU2013370297A1
(en)
|
2012-12-28 |
2015-07-16 |
Noven Pharmaceuticals, Inc. |
Multi-polymer compositions for transdermal drug delivery
|
JP2016505006A
(ja)
|
2012-12-28 |
2016-02-18 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
レボノルゲストレル及びエチニルエストラジオール用の経皮薬物送達システム
|
AU2013370290A1
(en)
*
|
2012-12-28 |
2015-07-16 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents
|
EP2941231B1
(en)
*
|
2013-01-02 |
2022-07-20 |
3M Innovative Properties Company |
A medical drape having an ultra-thin drape film and a thick adhesive coating
|
US20160008282A1
(en)
|
2013-02-22 |
2016-01-14 |
The Board Of Trustees Of The Universityof Illinois |
Transdermal Drug Delivery Using Amphiphilic Dendron-Coil Micelles
|
US11337936B2
(en)
|
2013-03-14 |
2022-05-24 |
Noven Pharmaceuticals, Inc. |
Amphetamine transdermal compositions with acrylic block copolymer
|
AU2014233453A1
(en)
|
2013-03-15 |
2015-10-01 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
AR095259A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
|
AR095260A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
|
BR112015032929B1
(pt)
|
2013-07-03 |
2022-08-23 |
Lts Lohmann Therapie-Systeme Ag |
Sistema terapêutico transdérmico com componente eletrônico e métodos de produção de um sistema terapêutico transdérmico
|
EP3144328B1
(en)
*
|
2014-05-12 |
2019-03-06 |
Mitsubishi Chemical Corporation |
Acrylic polymer, method for producing same, and plastisol composition including said acrylic polymer
|
CN106456568B
(zh)
|
2014-05-20 |
2020-03-27 |
Lts勒曼治疗系统股份公司 |
包含界面调节剂的经皮递送系统
|
CN106456566B
(zh)
|
2014-05-20 |
2020-06-16 |
Lts勒曼治疗系统股份公司 |
含罗替戈汀的经皮递送系统
|
JP6895755B2
(ja)
|
2014-05-20 |
2021-06-30 |
エルテーエス ローマン テラピー−ジステーメ アーゲー |
経皮送達システムにおける活性薬剤の放出を調節するための方法
|
JP5816881B2
(ja)
*
|
2014-05-21 |
2015-11-18 |
株式会社 メドレックス |
核酸を有効成分とする外用剤組成物
|
RU2016143081A
(ru)
|
2014-05-22 |
2018-06-26 |
Терапьютиксмд, Инк. |
Натуральные комбинированные гормонозаместительные составы и терапии
|
WO2016009279A2
(en)
|
2014-06-10 |
2016-01-21 |
Sabic Global Technologies B.V. |
Insecticide-containing coating composition and method for protecting palm trees from pests
|
US10238648B2
(en)
|
2014-07-18 |
2019-03-26 |
Buzzz Pharmaceuticals Ltd. |
Abuse deterrent opioid/opioid-antagonist transdermal patch
|
JP2017523138A
(ja)
|
2014-07-29 |
2017-08-17 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
経皮クリーム
|
AU2015296807A1
(en)
*
|
2014-07-31 |
2017-03-09 |
Noven Pharmaceuticals, Inc. |
Silicone-containing acrylic polymers for transdermal drug delivery compositions
|
CA2960626A1
(en)
|
2014-09-18 |
2016-03-24 |
Neuroderm, Ltd. |
Opipramol patch
|
US10010543B1
(en)
|
2014-12-23 |
2018-07-03 |
Barr Laboratories, Inc. |
Transdermal dosage form
|
JP2018511661A
(ja)
|
2015-01-29 |
2018-04-26 |
ダウ コーニング コーポレーションDow Corning Corporation |
シリコーンアクリレート組成物及びその調製方法
|
MX371044B
(es)
|
2015-02-06 |
2020-01-13 |
Noven Pharma |
Adhesivos sensibles a la presión para suministro transdérmico de fármaco.
|
US10406116B2
(en)
|
2015-02-06 |
2019-09-10 |
Noven Pharmaceuticals, Inc. |
Pressure-sensitive adhesives for transdermal drug delivery
|
CA2978438A1
(en)
*
|
2015-03-04 |
2016-09-09 |
Noven Pharmaceuticals, Inc. |
Oligomeric/polymeric silicone fluids for use in transdermal drug delivery systems
|
JP6526475B2
(ja)
*
|
2015-04-30 |
2019-06-05 |
サンスター株式会社 |
経皮唾液腺投与用の唾液分泌促進剤
|
MX2017014768A
(es)
*
|
2015-05-18 |
2018-03-23 |
Agile Therapeutics Inc |
Composiciones anticonceptivas y metodos para mejorar la eficacia y modulacion de los efectos secundarios.
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
JP6304457B2
(ja)
*
|
2015-08-27 |
2018-04-04 |
東洋インキScホールディングス株式会社 |
貼付剤
|
WO2017048595A1
(en)
*
|
2015-09-14 |
2017-03-23 |
Amneal Pharmaceuticals Llc |
Transdermal delivery system
|
CN108601749A
(zh)
|
2016-02-05 |
2018-09-28 |
3M创新有限公司 |
具有氟代硅氧烷剥离衬件的透皮药物递送体系
|
US9931349B2
(en)
|
2016-04-01 |
2018-04-03 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
JP7174632B2
(ja)
*
|
2016-06-23 |
2022-11-17 |
コリウム, インコーポレイテッド |
親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス
|
MX2019007391A
(es)
|
2016-12-20 |
2019-08-16 |
Lts Lohmann Therapie Systeme Ag |
Sistema terapeutico transdermico que contiene asenapina.
|
EP3558276A1
(en)
|
2016-12-20 |
2019-10-30 |
LTS Lohmann Therapie-Systeme AG |
Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
|
WO2019002204A1
(en)
|
2017-06-26 |
2019-01-03 |
Lts Lohmann Therapie-Systeme Ag |
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
|
WO2019186300A1
(en)
|
2018-03-28 |
2019-10-03 |
Sabic Global Technologies B.V. |
Peelable adhesive protective film to protect palm trees from the attack of red palm weevil pest
|
WO2019193514A1
(en)
|
2018-04-05 |
2019-10-10 |
3M Innovative Properties Company |
Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer
|
WO2019243452A1
(en)
|
2018-06-20 |
2019-12-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system containing asenapine
|
WO2020009685A1
(en)
|
2018-07-02 |
2020-01-09 |
John Tang |
Transdermal dosage form
|
WO2020008370A1
(en)
|
2018-07-02 |
2020-01-09 |
Clexio Biosciences Ltd. |
Transdermal patch
|
WO2020008366A1
(en)
|
2018-07-02 |
2020-01-09 |
Clexio Biosciences Ltd. |
Transdermal dosage form
|
WO2020013241A1
(ja)
*
|
2018-07-12 |
2020-01-16 |
積水化学工業株式会社 |
粘着剤組成物及び貼付剤
|
CN112206222A
(zh)
*
|
2018-11-09 |
2021-01-12 |
北京德默高科医药技术有限公司 |
含有布洛芬结构类似物的多层经皮给药系统
|
JP6912122B2
(ja)
*
|
2019-02-28 |
2021-07-28 |
日本臓器製薬株式会社 |
経皮投与製剤
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|